Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Anupam Rasayan has acquired up to a 43% stake in Bliss GVS Pharma, a pharmacy business in India, for about Rs 1,369 crore. Anupam Rasayan acquisitions focus on expanding healthcare M&A exposure through a strategic acquisition of Bliss GVS Pharma’s pharmaceutical capabilities. Bliss GVS Pharma operates in the pharmacy sector, supporting product development and distribution that can strengthen Anupam Rasayan’s presence in Indian healthcare markets. The Bliss GVS Pharma acquisition is structured as an add-on acquisition under strategic acquisition terms, with the deal announced and valued above $100 million.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026